You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Buprenorphine For Transdermal Analgesia
SBC: BIOTEK, INC. Topic: N/AWe will demonstrate the practical feasibility of transdermal analgesic therapy based onbuprenorphine, a potent opioid already used intravenously and intramuscularly for the relief of moderateto severe pain. Preliminary in vitro experiments have confirmed that buprenorphine can pass throughhuman skin at potentially therapeutic rates. Using BIOTEK's patented DermaPatch transdermal systemit should be ...
SBIR Phase I 1994 Department of Health and Human Services -
Biodegradable Antibiotic Beads for Osteomyletis
SBC: BIOTEK, INC. Topic: N/ADeep infection following open fractures or bone surgery are a challenging orthopedic problem. The ugentamicin-impregnated PMMA cement or beads has become a successful part of the management of osteomchronic post-fracture infections, but these materials have disadvantages, such as the need for a secthe PMMA, the existence of many gentamicin-immune organisms, and highly non-uniform delivery. The obp ...
SBIR Phase I 1995 Department of Health and Human Services -
Biodegradable Bone Matrix for Peptide Delivery
SBC: BIOTEK, INC. Topic: N/AThere is need for a convenient biodegradable bone substitute to support soft tissue and stimulate bWe will combine its unique BIOPORE material with the recently characterized osteogenic growth peptidthis objective. BIOPORE is a porous biodegradable material developed by BIOTEK. OGP is a 14-aminoacinormally present in serum, which stimulates proliferation and activity of osteoblasts and increasesde ...
SBIR Phase I 1995 Department of Health and Human Services -
Biodegradable Polylactide-Co Glycolide Medical Cements
SBC: BIOTEK, INC. Topic: N/AOsteomyelitis is a serious orthopedic problem, and its prevention or treatment using systemic antibcomplications and is often unsuccessful. The use of polymethylmethacrylate beads or bone cement to dto bone sites does reduce the incidence of post- operative bone infections, but these non-porous poldrug delivery vehicles, and because they are non-biodegradable materials they cannot be used where bd ...
SBIR Phase I 1995 Department of Health and Human Services -
BIODEGRADABLE LEVONORGESTREL CONTRACEPTIVE IMPLANTS
SBC: BIOTEK, INC. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
NEW METHOD FOR TREATING SLEEP DISORDERS IN THE AGED
SBC: BIOTEK, INC. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
BIODEGRADABLE MINERAL MICROSPHERE ADJUVANTS FOR VACCINES
SBC: BIOTEK, INC. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
TIN FREE CATALYST FOR BIODEGRADABLE POLYESTERS
SBC: BIOTEK, INC. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
NEW BIODEGRADABLE POLYMERS BASED ON MANDELIC ACID
SBC: BIOTEK, INC. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
AN ESTROGEN-PROGESTIN PATCH FOR ESTROGEN REPLACEMENT
SBC: BIOTEK, INC. Topic: N/AN/A
SBIR Phase I 1991 Department of Health and Human Services